Abstract
Beta-cell neogenesis is an attractive option for restoring beta-cell mass in diabetes. Recent findings indicate that beta-cells can be derived from alpha-cells under conditions of extreme beta-cell loss in mice. However, little is known about the potential of transdifferentiation capacity of human islet cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
